pubmed-article:15516291 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15516291 | lifeskim:mentions | umls-concept:C0039601 | lld:lifeskim |
pubmed-article:15516291 | lifeskim:mentions | umls-concept:C1524119 | lld:lifeskim |
pubmed-article:15516291 | lifeskim:mentions | umls-concept:C0001563 | lld:lifeskim |
pubmed-article:15516291 | lifeskim:mentions | umls-concept:C0017110 | lld:lifeskim |
pubmed-article:15516291 | lifeskim:mentions | umls-concept:C0033004 | lld:lifeskim |
pubmed-article:15516291 | lifeskim:mentions | umls-concept:C0456603 | lld:lifeskim |
pubmed-article:15516291 | lifeskim:mentions | umls-concept:C0870883 | lld:lifeskim |
pubmed-article:15516291 | lifeskim:mentions | umls-concept:C0037813 | lld:lifeskim |
pubmed-article:15516291 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
pubmed-article:15516291 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:15516291 | pubmed:dateCreated | 2004-11-1 | lld:pubmed |
pubmed-article:15516291 | pubmed:abstractText | The most frequently used method to demonstrate testosterone abuse is the determination of the testosterone and epitestosterone concentration ratio (T/E ratio) in urine. Nevertheless, it is known that factors other than testosterone administration may increase the T/E ratio. In the last years, the determination of the carbon isotope ratio has proven to be the most promising method to help discriminate between naturally elevated T/E ratios and those reflecting T use. In this paper, an excretion study following oral administration of 40 mg testosterone undecanoate initially and 13 h later is presented. Four testosterone metabolites (androsterone, etiocholanolone, 5 alpha-androstanediol, and 5 beta-androstanediol) together with an endogenous reference (5 beta-pregnanediol) were extracted from the urines and the delta(13)C/(12)C ratio of each compound was analyzed by gas chromatography-combustion-isotope ratio mass spectrometry. The results show similar maximum delta(13)C-value variations (parts per thousand difference of delta(13)C/(12)C ratio from the isotope ratio standard) for the T metabolites and concomitant changes of the T/E ratios after administration of the first and the second dose of T. Whereas the T/E ratios as well as the androsterone, etiocholanolone and 5 alpha-androstanediol delta(13)C-values returned to the baseline 15 h after the second T administration, a decrease of the 5 beta-androstanediol delta-values could be detected for over 40 h. This suggests that measurements of 5 beta-androstanediol delta-values allow the detection of a testosterone ingestion over a longer post-administration period than other T metabolites delta(13)C-values or than the usual T/E ratio approach. | lld:pubmed |
pubmed-article:15516291 | pubmed:language | eng | lld:pubmed |
pubmed-article:15516291 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15516291 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15516291 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15516291 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15516291 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15516291 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15516291 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15516291 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15516291 | pubmed:month | Sep | lld:pubmed |
pubmed-article:15516291 | pubmed:issn | 0146-4760 | lld:pubmed |
pubmed-article:15516291 | pubmed:author | pubmed-author:ManginPatrice... | lld:pubmed |
pubmed-article:15516291 | pubmed:author | pubmed-author:SaugyMartialM | lld:pubmed |
pubmed-article:15516291 | pubmed:author | pubmed-author:SaudanChristo... | lld:pubmed |
pubmed-article:15516291 | pubmed:author | pubmed-author:MaîtreArnaudA | lld:pubmed |
pubmed-article:15516291 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15516291 | pubmed:volume | 28 | lld:pubmed |
pubmed-article:15516291 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15516291 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15516291 | pubmed:pagination | 426-31 | lld:pubmed |
pubmed-article:15516291 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:15516291 | pubmed:meshHeading | pubmed-meshheading:15516291... | lld:pubmed |
pubmed-article:15516291 | pubmed:meshHeading | pubmed-meshheading:15516291... | lld:pubmed |
pubmed-article:15516291 | pubmed:meshHeading | pubmed-meshheading:15516291... | lld:pubmed |
pubmed-article:15516291 | pubmed:meshHeading | pubmed-meshheading:15516291... | lld:pubmed |
pubmed-article:15516291 | pubmed:meshHeading | pubmed-meshheading:15516291... | lld:pubmed |
pubmed-article:15516291 | pubmed:meshHeading | pubmed-meshheading:15516291... | lld:pubmed |
pubmed-article:15516291 | pubmed:meshHeading | pubmed-meshheading:15516291... | lld:pubmed |
pubmed-article:15516291 | pubmed:meshHeading | pubmed-meshheading:15516291... | lld:pubmed |
pubmed-article:15516291 | pubmed:meshHeading | pubmed-meshheading:15516291... | lld:pubmed |
pubmed-article:15516291 | pubmed:meshHeading | pubmed-meshheading:15516291... | lld:pubmed |
pubmed-article:15516291 | pubmed:meshHeading | pubmed-meshheading:15516291... | lld:pubmed |
pubmed-article:15516291 | pubmed:meshHeading | pubmed-meshheading:15516291... | lld:pubmed |
pubmed-article:15516291 | pubmed:meshHeading | pubmed-meshheading:15516291... | lld:pubmed |
pubmed-article:15516291 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15516291 | pubmed:articleTitle | Urinary analysis of four testosterone metabolites and pregnanediol by gas chromatography-combustion-isotope ratio mass spectrometry after oral administrations of testosterone. | lld:pubmed |
pubmed-article:15516291 | pubmed:affiliation | Laboratoire Suisse d'Analyse du Dopage, Institut Universitaire de Médecine Légale, Rue du Bugnon 21, 1005 Lausanne, Switzerland. | lld:pubmed |
pubmed-article:15516291 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15516291 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:15516291 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15516291 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15516291 | lld:pubmed |